At a glance
We’re excited to connect with you at this conference. Prosigna will be in attendance — reach out ahead of the event if you’d like to set up a time to meet.
Learn how the Prosigna Breast Risk of Recurrence test helps guide informed personalized treatment decisions for early-stage, hormone receptor positive (HR+), breast cancer.
Check back soon for details on presentations and posters.
Meet with us
Interested in connecting with our team at this event? We’d love to hear from you.
Tags
Europe
Prosigna Breast